BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30699866)

  • 1. Empirically-derived response trajectories of intensive residential treatment in obsessive-compulsive disorder: A growth mixture modeling approach.
    Falkenstein MJ; Nota JA; Krompinger JW; Schreck M; Garner LE; Potluri S; Van Kirk N; Ponzini G; Tifft E; Brennan BP; Mathes B; Cattie J; Crosby JM; Elias JA
    J Affect Disord; 2019 Feb; 245():827-833. PubMed ID: 30699866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.
    Brennan BP; Lee C; Elias JA; Crosby JM; Mathes BM; Andre MC; Gironda CM; Pope HG; Jenike MA; Fitzmaurice GM; Hudson JI
    J Psychiatr Res; 2014 Sep; 56():98-105. PubMed ID: 24909787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.
    Stewart SE; Yen CH; Stack DE; Jenike MA
    J Psychiatr Res; 2006 Sep; 40(6):511-9. PubMed ID: 16229857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of acute outcomes for intensive residential treatment of obsessive-compulsive disorder.
    Siwiec SG; Riemann BC; Lee HJ
    Clin Psychol Psychother; 2019 Nov; 26(6):661-672. PubMed ID: 31273851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of the therapeutic working alliance as a factor in intensive residential treatment of obsessive-compulsive disorder.
    Wheaton MG; Mcingvale E; Van Meter AR; Björgvinsson T
    Psychother Res; 2023 Apr; 33(4):442-454. PubMed ID: 36314194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of treatment outcome for youth receiving intensive residential treatment for obsessive-compulsive disorder (OCD).
    Højgaard DRMA; Schneider SC; La Buissonnière-Ariza V; Kay B; Riemann BC; Jacobi D; Eken S; Lake P; Nadeau J; Goodman WK; McIngvale E; Storch EA
    Cogn Behav Ther; 2020 Jul; 49(4):294-306. PubMed ID: 31203735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and impacts of intersectionality on obsessive-compulsive disorder symptoms across intensive treatment.
    Wadsworth LP; Potluri S; Schreck M; Hernandez-Vallant A
    Am J Orthopsychiatry; 2020; 90(4):445-457. PubMed ID: 32134311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-occurring PTSD in intensive OCD treatment: Impact on treatment trajectory vs. response.
    Pinciotti CM; Van Kirk N; Horvath G; Storch EA; Mancebo MC; Abramowitz JS; Fontenelle LF; Goodman WK; Riemann BC; Cervin M
    J Affect Disord; 2024 May; 353():109-116. PubMed ID: 38452939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of depression on the treatment of OCD in a residential sample.
    Wetterneck CT; Leonard RC; Adams TG; Riemann BC; Grau P; Franklin ME
    Bull Menninger Clin; 2020 Oct; 84(Supplement A):12-33. PubMed ID: 33074022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder.
    Stewart SE; Stack DE; Farrell C; Pauls DL; Jenike MA
    J Psychiatr Res; 2005 Nov; 39(6):603-9. PubMed ID: 16157162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of specialized residential treatment for adults with obsessive-compulsive disorder.
    Björgvinsson T; Hart AJ; Wetterneck C; Barrera TL; Chasson GS; Powell DM; Heffelfinger S; Stanley MA
    J Psychiatr Pract; 2013 Sep; 19(5):429-37. PubMed ID: 24042250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of intensive treatment services for obsessive compulsive disorder: outcomes from the first Canadian residential treatment program.
    Taube-Schiff M; Rector NA; Larkin P; Mehak A; Richter MA
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):59-67. PubMed ID: 31670999
    [No Abstract]   [Full Text] [Related]  

  • 14. Residential treatment outcomes for adolescents with obsessive-compulsive disorder.
    Leonard RC; Franklin ME; Wetterneck CT; Riemann BC; Simpson HB; Kinnear K; Cahill SP; Lake PM
    Psychother Res; 2016 Nov; 26(6):727-36. PubMed ID: 26308588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trajectory in obsessive-compulsive disorder comorbidities.
    de Mathis MA; Diniz JB; Hounie AG; Shavitt RG; Fossaluza V; Ferrão Y; Leckman JF; de Bragança Pereira C; do Rosario MC; Miguel EC
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):594-601. PubMed ID: 22921470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online Video Teletherapy Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention: Clinical Outcomes From a Retrospective Longitudinal Observational Study.
    Feusner JD; Farrell NR; Kreyling J; McGrath PB; Rhode A; Faneuff T; Lonsway S; Mohideen R; Jurich JE; Trusky L; Smith SM
    J Med Internet Res; 2022 May; 24(5):e36431. PubMed ID: 35587365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year course of obsessive-compulsive disorder: predictors of remission and relapse.
    Eisen JL; Sibrava NJ; Boisseau CL; Mancebo MC; Stout RL; Pinto A; Rasmussen SA
    J Clin Psychiatry; 2013 Mar; 74(3):233-9. PubMed ID: 23561228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for successful implementation of exposure and response prevention in a naturalistic group format for pediatric OCD.
    Olino TM; Gillo S; Rowe D; Palermo S; Nuhfer EC; Birmaher B; Gilbert AR
    Depress Anxiety; 2011 Apr; 28(4):342-8. PubMed ID: 21456041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying trajectories of symptom change in adults with obsessive compulsive disorder receiving exposure and response prevention therapy.
    Kim H; Wheaton MG; Foa EB; Simpson HB
    J Anxiety Disord; 2023 May; 96():102711. PubMed ID: 37148799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features associated to refractory obsessive-compulsive disorder.
    Ferrão YA; Shavitt RG; Bedin NR; de Mathis ME; Carlos Lopes A; Fontenelle LF; Torres AR; Miguel EC
    J Affect Disord; 2006 Aug; 94(1-3):199-209. PubMed ID: 16764938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.